Compare BFI Finance Indonesia Tbk (BFIN) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BFI Finance Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? BFI Finance Indonesia Tbk trades at Rp785 (market cap 12.03T, 12.2M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: BFI Finance Indonesia Tbk is far larger — about 20.6× UBC Medical Indonesia Tbk.'s market cap, and BFI Finance Indonesia Tbk is more actively traded (12.2M versus 1.44M). Which is the better fit depends on your goals.
| BFIN | LABS | |
|---|---|---|
Market Cap | 12.03T | 584.6B |
Volume | 12.2M | 1.44M |
Lot | 122K | 14.4K |
Turnover | 9.55B | 209.72M |
Average Price | 782.93 | 145.64 |
Value | 9.55B | 209.72M |
Indicative Equilibrium Price | 785 | 146 |
Indicative Equilibrium Volume | 5.52K | 753 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BFI Finance Indonesia Tbk
PT BFI Finance Indonesia Tbk (the Company) formerly PT. Bunas Finance Indonesia Tbk (the Company) was established as PT Manufacturers Hanover Leasing Indonesia on April 7, 1982 based on Notarial deed No. 57 of Kartini Muljadi, S.H., Notary in Jakarta. Presently, the Company is engaged in leasing, consumer financing and factoring of accounts receivable. And changed to BFI Finance Indonesia on 2001
Read more on BFIN →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
